Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Speakers and Panels

Randal Froebelius

Randal Froebelius

Project Executive & Senior Adviser

MaRS Discovery District

Matthew Johnson

Matthew Johnson

Senior Vice President

Colliers International

Sonya Donovan

Sonya Donovan

Managing Director, Real Estate

University of Toronto

Randal Froebelius

Project Executive & Senior Adviser

MaRS Discovery District

Randal Froebelius has been a senior member of the MaRS Discovery District Real

Estate team for over 18 years participating in the design, construction, property

management, leasing and financing of the MaRS Centre, North America’s

largest urban innovation hub, located in Toronto. He is currently Project

Executive and Senior Adviser to MaRS and led the design and construction of the

MaRS Nucleus space at the Waterfront Innovation Centre in Toronto.

Randal is currently Chair of the Building Owners and Managers Association

(BOMA) International, and is a Past-Chair of BOMA Canada, BOMA Toronto and

the BOMA Floor Measurement Standards Committee. In 2019, he became a

BOMA Fellow.

Randal also serves on the boards of the Northern Centre for Advanced

Technology in Sudbury, Ontario, and Halmont Properties Corporation.

Randal has 35 years of experience in property management, leasing, project

management and construction. Randal holds a Bachelor of Engineering

Science (Civil) degree from the University of Western Ontario, an MBA from the

Richard Ivey School of Business, a Master of Laws from the University of Toronto

and is a Licensed Professional Engineer in the Province of Ontario. He has held

progressive positions with construction, real estate development and

management companies throughout his career.

Sonya Donovan

Managing Director, Real Estate

University of Toronto

Sonya Donovan is the Managing Director, Real Estate at the University of Toronto. Prior to her current position, Sonya was the Director of Real Estate at the University of Guelph, where she spearheaded the implementation of the real estate development strategy for the University’s extensive non-academic real estate land holdings. Sonya worked at Oxford Properties for several years holding progressively senior roles in investments, leasing, and development.

Sonya sits on the board of CRE8, a not-for-profit organization that she co-founded with four other women to help increase the advancement and participation of women in the commercial real estate sector. Sonya is a CPA, CA, and an Honours Business Administration degree from the Richard Ivey School of Business at University of Western Ontario.

The State of Life Sciences Real Estate: Can This Market Get Moving Again?

Gordon McCauley

Gordon McCauley

CEO

adMare Bioinnovations

Mike Pereira

Mike Pereira

University of Waterloo

Director, Real Estate and R+T Park

Ryan Gregory

Ryan Gregory

VP of Life Sciences Facilities

Merrick

Rishi Nandi

Rishi Nandi

Science+Technology Lead

DIALOG

Daniel Lacey
Moderator

Daniel Lacey

Associate VP

CBRE

Gordon McCauley

CEO

adMare Bioinnovations

Gordon C. McCauley was appointed President and CEO of adMare BioInnovations in 2016 after four years on the Board. Gordon has demonstrated leadership in various roles, notably executive and investment management in public and private biotech companies and venture capital firms. Additionally, Gordon was a senior advisor to several prominent Canadian political leaders and has integrated this experience into his work within the life sciences sector.

Gordon is currently the Chair of CGEn, Canada's national genomics enterprise. He is an independent Director of Forus Therapeutics and Montreal InVivo. Gordon Co-Chairs the Canadian Chamber of Commerce Life Science Council and is actively engaged with the Canadian Public Policy Forum Life Sciences Leadership Table.

Previously, Gordon has been Chair of BIOTECanada, LifeSciences British Columbia, Acetech, and The Toronto Rehab Foundation. In 2008, he was the first Canadian to join the Board of the Biotechnology Industry Organization (BIO) in Washington, D.C., serving in leadership roles until 2013.

Gordon holds a B.A. in Political Science from McMaster University, an MBA (with honours) from IMD in Lausanne, Switzerland, and earned the ICD.D certification from the Institute of Corporate Directors and the Rotman School of Business at the University of Toronto. He is currently a doctoral candidate at Grenoble École de Management in Grenoble, France.

Ryan Gregory

VP of Life Sciences Facilities

Merrick

Ryan Gregory, Merrick’s VP of Life Sciences Facilities, has a background in mechanical engineering and facility commissioning specializing in life sciences laboratories with a specific focus in high containment. As the leader of laboratory projects across Canada and internationally, Ryan has participated in and led interdisciplinary teams of designers and lab users from project inception through design, commissioning, licensing and ongoing operational support. Ryan’s experience has led to an appreciation for the “whys” behind current and future program requirements in order to achieve desired facility outcomes in an efficient and sustainable manner.

Rishi Nandi

Science+Technology Lead

DIALOG

Rishi Nandi is an architectural leader with over 20 years of experience planning and delivering complex research and life sciences environments. His work spans strategic planning, adaptive reuse, renovation, and new construction, with a focus on long-term operational performance and asset stewardship. He brings deep U.S.-based expertise to support DIALOG’s national Science+Technology practice, leading interdisciplinary teams to deliver flexible, high-performance research environments that balance design ambition, regulatory requirements, and financial discipline.

Why You Should Attend the Toronto Life Sciences and Biotech Summit

Why This Matters

Toronto’s life sciences real estate market is at a turning point. Developers have delivered purpose-built lab space, but much of it remains vacant. Early-stage tenants are grappling with high buildout costs, tighter capital markets, and slow funding cycles. At the same time, major institutional players are circling, public-private partners are mobilizing, and academic institutions continue to produce world-class research. The question isn’t whether life sciences will grow, it’s who can actually take space, secure financing, and drive tenancy today. This event convenes real estate leaders, biotech execs, and innovation economy insiders to map out where the real opportunities are in 2026.

What You Will Learn

  • A Perfect Storm of Headwinds: Unlike past cycles, today multiple factors are depressing demand simultaneously. Both venture funding and federal research grants have pulled back at the same time, draining fuel from the startup pipeline. The NIH is about $5 billion behind in grant awards in 2025 versus 2024, and life science companies raised just $24.9 billion in VC through Q3 2025 – on track for the lowest funding haul since pre-pandemic. This rare convergence of challenges has led even strong markets into a slump. Hear how long these funding and demand woes might persist.

  • Talent as the Magnet: Ultimately, talent is the lifeblood of life sciences and thus of life science real estate. In a recent industry survey, 57% of life sciences executives cited attracting/retaining talent as a top priority for the next five year. Hear how real estate and cluster development intersect with talent considerations. For example, location matters: companies want to be where the scientists want to live. That could mean vibrant urban neighborhoods or live-work-play innovation districts that appeal to young professionals. Amenities like daycare or convenient transit also factor into a talent-friendly ecosystem. Hear about collaborations with universities to ensure a pipeline of graduates in biotech, and retraining programs that convert workers from other industries into lab technicians to meet demand.

  • Flight to Quality in an Uncertain Market: Not all lab space is suffering equally. Prime, amenity-rich campuses are still capturing demand before commodity space. Consolidation in the industry means if a company does lease space now, they’re likely choosing the best-in-class buildings. High-quality facilities in coveted locations (near top research institutes or urban innovation districts) are outperforming secondary assets. The discussion will highlight this “two-tier” market: modern lab product with premium infrastructure and perks (collaboration spaces, fitness centers, proximity to talent) continues to see interest, while older or fringe properties languish. Quality and location have become make-or-break, and owners of Class B lab buildings face tough decisions ahead.

  • Long-Term Optimism vs. Short-Term Pain: Are current conditions a temporary correction or a fundamental shift? Despite the shakeout, many maintain that bioresearch is a growth industry long-term, and scientific advances in areas like oncology, gene therapy, and immunology will spawn new companies and therapies. Panelists will discuss the timeline of recovery. With experts noting the sector is oversaturated now but retains strong long-range potential, how can stakeholders position themselves? The conversation will conclude on forward-looking insights: which markets or niches could rebound first, and how events like an aging population and technological breakthroughs (AI in drug discovery, personalized medicine) will drive the next wave of life sciences real estate demand.

     

For questions regarding content and speaking, please email our Director, Event Production, Virginia Baker, at Virginia.Baker@bisnow.com. Want to get involved? Contact Dane.Sinks@bisnow.com or Max.Kleinberg@bisnow.com  to get information on sponsorship, pricing and availability at this event. To request disability-related accommodations, please contact mackenzie.kunkle@bisnow.com no later than seven business days prior to the event.

DON'T MISS OUR PREMIER LIFE SCIENCES & BIOTECH EVENT THIS FALL: Announcing our fourth annual Bisnow International Life Sciences & Biotech Conference, September 1st and 2nd in San Diego, CA. Learn more about our largest event of the year by clicking here.

Venue

The Omni King Edward Hotel
37 King St E
Toronto, CA ON M5C 1E9

Ballroom: Windsor Ballroom
Floor: Lower Level


Valet: $60 CAD
Nearby self-parking options include CitiPark at 65 King Street East (adjacent to the hotel, starting around $22.50 CAD daily)

Get Directions

Agenda

Time Activity
12:00 PM
1:30 PM
Registration, Networking, & Breakfast
1:30 PM
2:30 PM
The State of Life Sciences Real Estate: Can This Market Get Moving Again?

Great science needs more than lab space. It needs capital, talent, institutional support, and a strong local ecosystem. As Canada’s life sciences real estate market faces stalled leasing, tighter funding, and slower development activity, this panel will explore what it takes to create momentum again. From development and capital markets to incubators, accelerators, university partnerships, and public sector initiatives, the discussion will examine how deals are getting done today and what ingredients are necessary to build a more active, competitive, and sustainable life sciences cluster.

2:30 PM
3:00 PM
Post-panel Networking

Sponsors